The probiotic ingredients market would grow at a CAGR of 12.42% over the predicted time frame. The market is expected to increase in value from US$ 5,591.41 Mn in 2022 to US$ 14,269 Mn in 2030.
The on probiotic
ingredients Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1826
Report Scope of the Probiotic Ingredients Market
Report Coverage | Details |
Market Size by 2030 | USD 14,269 Million |
Growth Rate from 2022 to 2030 | CAGR of 12.42% |
Europe Market Share in 2021 | 38% |
Fastest Growing Region | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | ProbioFerm, Glac Biotech, DSM, Vitakem Nutraceutical, Inc., Bio Gaia, Probium, Kerry Group |
A recent
report provides crucial insights along with application based and forecast
information in the Global Probiotic ingredients Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Probiotic ingredients market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Probiotic ingredients
market are included as given below:
Probiotic ingredients Market Key Players
- ProbioFerm
- Glac Biotech
- DSM
- Vitakem Nutraceutical, Inc.
- Bio Gaia
- Probium
- Kerry Group
Market Segments
- Bifidobacterium animalis
- Bifidobacterium breve
- Bifidobacterium longum
- Lactobacillus Reuteri
By Application
- Food and Beverages
- Dairy Products
- Yogurt
- Cheese
- Other
- Non-dairy Products
- Vegetable-based probiotic products
- Fruit-based probiotic products
- Meat-based probiotic products
- Dairy Products
- Dietary Supplements
- Tablets
- Probiotic Drinks
- Powders
- Capsules
- Powder
- Granule
- Animal Feed
By Components
- Bacterica
- Yeast
By Form
- Dry Form
- Liquid Form
By End User
- Human Probiotic
- Animal Probiotic
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global probiotic
ingredients market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the probiotic
ingredients market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Probiotic Ingredients Market
5.1. COVID-19 Landscape: Probiotic Ingredients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Probiotic Ingredients Market, By Type
8.1. Probiotic Ingredients Market, by Type, 2022-2030
8.1.1. Bifidobacterium animalis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bifidobacterium breve
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Bifidobacterium longum
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Lactobacillus Reuteri
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Probiotic Ingredients Market, By Application
9.1. Probiotic Ingredients Market, by Application, 2022-2030
9.1.1. Food and Beverages
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Animal Feed
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Probiotic Ingredients Market, By Components
10.1. Probiotic Ingredients Market, by Components, 2022-2030
10.1.1. Bacterica
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Yeast
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Probiotic Ingredients Market, By Form
11.1. Probiotic Ingredients Market, by Form, 2022-2030
11.1.1. Dry Form
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Liquid Form
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Probiotic Ingredients Market, By End User
12.1. Probiotic Ingredients Market, by End User, 2022-2030
12.1.1. Human Probiotic
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Animal Probiotic
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Probiotic Ingredients Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.7. Market Revenue and Forecast, by End User (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.7. Market Revenue and Forecast, by Form (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.10. Market Revenue and Forecast, by Form (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. ProbioFerm
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Glac Biotech
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DSM
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Vitakem Nutraceutical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio Gaia
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Probium
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kerry Group
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments